mifepristone has been researched along with Adenocarcinoma in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.86) | 18.7374 |
| 1990's | 16 (45.71) | 18.2507 |
| 2000's | 15 (42.86) | 29.6817 |
| 2010's | 2 (5.71) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Bellini, R; Biagioli, M; Bordoni, M; Catalanotti, B; Di Giorgio, C; Distrutti, E; Fiorucci, S; Lupia, A; Marchianò, S; Massa, C; Monti, MC; Moraca, F; Morretta, E; Roselli, R; Sepe, V; Urbani, G; Zampella, A | 1 |
| Lyu, Y; Shang, L; Wang, Y | 1 |
| Choi, YH; Jang, JH; Kim, SH; Kwon, TK; Lee, TJ; Min, KJ; Park, EJ; Um, HJ; Woo, SM | 1 |
| Fabri, PJ; Godellas, CV; Gower, WR; Risch, RM | 1 |
| Atkinson, N; Broaddus, R; Burke, T; Iyer, RB; Johnson, AJ; Jung, MS; Ramondetta, LM; Smith, JA; Sun, CC | 1 |
| Aligiannis, N; Kassi, E; Moutsatsou, P; Papoutsi, Z; Pratsinis, H; Sourlingas, TG; Spiliotaki, M | 1 |
| Check, D; Check, JH; Dix, E; Sansoucie, L | 1 |
| Chao, V; Dreher, E; Mueller, MD; Pritts, EA; Taylor, RN; Vigne, JL | 1 |
| Bai, J; Du, YH; Hu, K; Li, DQ; Wang, Y; Wang, ZB; Zhao, J | 2 |
| Archer, DF; Mirkin, S | 1 |
| Amezcua, CA; Felix, JC; Jain, JK; Li, A; Minoo, P | 1 |
| Chen, CL; Liao, QP; Lu, Y; Yu, L | 1 |
| Chang, CY; Elbi, C; Hager, GL; Hendarwanto, A; Klokk, TI; Kurys, P; Nagaich, AK; Saatcioglu, F; Slagsvold, T | 1 |
| Davis, JR; Kakar, M; Kern, SE; Lim, CS | 1 |
| Dong, A; Hu, J; Liu, X; Xu, H; Zhao, L | 1 |
| Adachi, Y; Ikehara, S; Iwasaki, M; Kamiyama, Y; Koike-Kiriyama, N; Mukaide, H; Shi, M; Shigematsu, A; Taketani, S; Yanai, S; Yoshioka, K | 1 |
| Charreau, EH; Dran, G; Lanari, C; Luthy, IA; Molinolo, AA; Montecchia, F; Pasqualini, CD | 1 |
| Gravanis, A; Makrigiannakis, A; Margioris, AN; Stournaras, C | 1 |
| Chang, TJ; Chang, YF; Chi, CW; Lui, WY; P'Eng, FK; Wu, CW; Yeh, TH | 1 |
| Falany, CN; Falany, JL | 1 |
| Bamberger, AM; Bamberger, CM; Gellersen, B; Schulte, HM | 1 |
| Chrousos, GP; Gravanis, A; Makrigiannakis, A; Margioris, AN; Stournaras, C; Zoumakis, E | 1 |
| Castelbaum, AJ; Chwalisz, K; Ilesanmi, AO; Lessey, BA; Satyaswaroop, PG; Somkuti, SG; Yuan, L | 1 |
| Gurpide, E; Markiewicz, L | 1 |
| de Coupade, C; Flower, RJ; Parente, L; Russo-Marie, F; Solito, E | 2 |
| Charreau, E; Lamb, C; Lanari, C; Luthy, IA; Molinolo, AA; Montecchia, MF; Pazos, P; Vanzulli, S | 1 |
| Daly, JM; Evoy, D; Fujita, J; Mackrell, P; McCarter, MD; Naama, HA; Rivadeneira, DE | 1 |
| McDonnel, AC; Murdoch, WJ | 1 |
| Arnold, JT; Kaufman, DG; Lessey, BA; Seppälä, M | 1 |
| Croxtall, JD; Flower, RJ | 1 |
| Azuma, C; Kimura, T; Miki, M; Ono, M; Saji, F; Takemura, M; Tanizawa, O; Tokugawa, Y | 1 |
| Kokai, Y; Lyttle, CR; Modiano, JF; Nowell, PC; Pykett, MJ; Weiner, DB | 1 |
| Bons, EG; Lamberts, SW; Uitterlinden, P; Verleun, T | 1 |
2 trial(s) available for mifepristone and Adenocarcinoma
| Article | Year |
|---|---|
Clinical effect of mifepristone on patients with ovarian cancer in pregnancy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemotherapy, Adjuvant; Female; Humans; Mifepristone; Neoplasm Staging; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy, High-Risk | 2019 |
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Endometrioid; Female; Hormone Antagonists; Humans; Middle Aged; Mifepristone; Neoplasms, Hormone-Dependent; Receptors, Progesterone; Recurrence; Sarcoma, Endometrial Stromal | 2009 |
33 other study(ies) available for mifepristone and Adenocarcinoma
| Article | Year |
|---|---|
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Drug Repositioning; Female; Hormone Antagonists; Humans; Mifepristone; Pancreatic Neoplasms; Pregnancy; Receptors, OSM-LIF | 2022 |
RU486, a glucocorticoid receptor antagonist, induces apoptosis in U937 human lymphoma cells through reduction in mitochondrial membrane potential and activation of p38 MAPK.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Colorectal Neoplasms; Cytochromes c; Enzyme Activation; Female; HCT116 Cells; Hormone Antagonists; Humans; Leukemia; Lung Neoplasms; Lymphoma; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mifepristone; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Receptors, Glucocorticoid; U937 Cells | 2013 |
HPAC, a new human glucocorticoid-sensitive pancreatic ductal adenocarcinoma cell line.
Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Dexamethasone; Dose-Response Relationship, Drug; Hormone Antagonists; Humans; Hydrocortisone; Insulin; Karyotype; Male; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Pancreatic Neoplasms; Receptors, Glucocorticoid; Transforming Growth Factor alpha; Xenograft Model Antitumor Assays | 1994 |
Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells.
Topics: Active Transport, Cell Nucleus; Adenocarcinoma; Antineoplastic Agents; Apoptosis; Binding, Competitive; Breast Neoplasms; Cell Line, Tumor; Dexamethasone; Down-Regulation; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; HeLa Cells; Humans; Mifepristone; Neoplasm Proteins; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-bcl-2; Receptors, Glucocorticoid; Transcription Factor AP-1; Transcription, Genetic; Triamcinolone; Triterpenes; Ursolic Acid | 2009 |
Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case report.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Colonic Neoplasms; Disease Progression; Female; Humans; Male; Middle Aged; Mifepristone; Neoplasm Metastasis; Quality of Life | 2009 |
Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endothelial Growth Factors; Female; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Medroxyprogesterone; Mifepristone; Promegestone; Receptors, Progesterone; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Effects of mifepristone on invasive and metastatic potential of human gastric adenocarcinoma cell line MKN-45 in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Cell Adhesion; Cell Line, Tumor; Hormone Antagonists; Humans; In Vitro Techniques; Integrin beta3; Mice; Mice, Nude; Mifepristone; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2004 |
Effects of mifepristone on proliferation of human gastric adenocarcinoma cell line SGC-7901 in vitro.
Topics: Adenocarcinoma; Apoptosis; bcl-X Protein; Caspase 3; Caspases; Cell Division; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; In Vitro Techniques; Mifepristone; Proto-Oncogene Proteins c-bcl-2; Receptors, Progesterone; RNA, Messenger; Stomach Neoplasms | 2004 |
Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
Topics: Adenocarcinoma; Cell Line; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Endometrial Neoplasms; Endometrium; Epithelial Cells; Estradiol; Female; Gene Expression; Hormone Antagonists; Humans; Mifepristone; Progesterone; RNA, Messenger; Thrombospondin 1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2004 |
Effect of mifepristone on proliferation and apoptosis of Ishikawa endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Mifepristone | 2005 |
[Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Topics: Adenocarcinoma; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Estradiol; Female; Humans; Mifepristone; Oligodeoxyribonucleotides, Antisense; Promegestone; Receptors, Progesterone; Transfection | 2006 |
Ligand-specific dynamics of the androgen receptor at its response element in living cells.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Animals; Cell Line, Tumor; Chromatin Assembly and Disassembly; Cyproterone Acetate; Dihydrotestosterone; Female; Fluorescence Recovery After Photobleaching; Flutamide; Genes, Reporter; Green Fluorescent Proteins; In Situ Hybridization, Fluorescence; Ligands; Luciferases; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Metribolone; Mice; Microscopy, Video; Mifepristone; Models, Biological; Nitriles; Plasmids; Promoter Regions, Genetic; Receptors, Androgen; Response Elements; Testosterone; Tosyl Compounds; Transcription, Genetic | 2007 |
Optimizing the protein switch: altering nuclear import and export signals, and ligand binding domain.
Topics: Active Transport, Cell Nucleus; Adenocarcinoma; Amino Acid Sequence; Animals; Antigens, Polyomavirus Transforming; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Dexamethasone; Electroporation; Gene Products, rev; Ligands; Mice; Mifepristone; Mitogen-Activated Protein Kinase Kinases; Nuclear Export Signals; Plasmids; Protein Structure, Tertiary; Protein Transport; Proteins; Receptors, Glucocorticoid; Receptors, Progesterone | 2007 |
Regulation and pharmacokinetics of inducible recombinant TRAIL expression.
Topics: Adenocarcinoma; Adenoviridae; Amino Acid Sequence; Animals; Apoptosis; Base Sequence; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Genes, Synthetic; Genetic Vectors; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Molecular Sequence Data; Promoter Regions, Genetic; Protein Structure, Tertiary; Recombinant Fusion Proteins; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2007 |
FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma.
Topics: Adenocarcinoma; Cell Division; Colon; Colorectal Neoplasms; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Methylprednisolone; Mifepristone; Neoplasm Proteins; Receptors, Glucocorticoid; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Tacrolimus Binding Proteins; Tumor Cells, Cultured | 2008 |
Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
Topics: Adenocarcinoma; Androgen Antagonists; Animals; Blood Physiological Phenomena; Cell Division; Dexamethasone; Dihydrotestosterone; Estradiol; Female; Flutamide; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mifepristone; Ovariectomy; Progesterone; Tumor Cells, Cultured | 1995 |
Interaction between steroid hormones and endometrial opioids.
Topics: Adenocarcinoma; Animals; beta-Endorphin; Blotting, Northern; Dexamethasone; Dynorphins; Endometrial Neoplasms; Estradiol; Female; Hormones; Humans; Male; Mifepristone; Potassium Chloride; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured | 1994 |
Steroid hormone receptors in three human gastric cancer cell lines.
Topics: Adenocarcinoma; Animals; Cell Cycle; Estradiol; Flow Cytometry; Humans; Hydrocortisone; Male; Mice; Mice, Inbred ICR; Mice, Nude; Mifepristone; Neoplasm Transplantation; Progesterone; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; Stomach Neoplasms; Tamoxifen; Tumor Cells, Cultured | 1994 |
Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone.
Topics: Adenocarcinoma; Endometrial Neoplasms; Estrone; Female; Humans; Mifepristone; Progesterone; RNA, Messenger; Sulfates; Sulfotransferases; Tumor Cells, Cultured | 1996 |
Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Animals; Base Sequence; Cell Line; Endometrial Neoplasms; Female; Haplorhini; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Mifepristone; Molecular Sequence Data; Promoter Regions, Genetic; Receptors, Estrogen; Receptors, Progesterone; Transcription Factor AP-1; Transfection; Tumor Cells, Cultured | 1996 |
Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells.
Topics: Adenocarcinoma; Corticotropin-Releasing Hormone; Cyclic AMP; Dexamethasone; Dinoprostone; Endometrial Neoplasms; Endometrium; Epidermal Growth Factor; Estradiol; Female; Gene Expression Regulation; Humans; Indomethacin; Luciferases; Mifepristone; Promoter Regions, Genetic; Recombinant Fusion Proteins; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 1996 |
Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin.
Topics: Adenocarcinoma; Endometrial Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Integrin alpha1beta1; Integrins; Mifepristone; Neoplasm Proteins; Progesterone; Protein Biosynthesis; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; Transcription, Genetic; Tumor Cells, Cultured | 1996 |
Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured | 1997 |
Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549: involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1.
Topics: Adenocarcinoma; Annexin A1; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Dexamethasone; Dipeptidyl Peptidase 4; DNA-Binding Proteins; Epithelial Cells; Glucocorticoids; Hormone Antagonists; Humans; Lung Neoplasms; Mifepristone; Nuclear Proteins; Promoter Regions, Genetic; Recombinant Fusion Proteins; Sequence Deletion; Tetradecanoylphorbol Acetate; Transcription Factors; Transcriptional Activation; Transfection; Tumor Cells, Cultured | 1998 |
IL-6 stimulates annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein.
Topics: Acute-Phase Proteins; Adenocarcinoma; Annexin A1; CCAAT-Enhancer-Binding Proteins; Cloning, Molecular; Dexamethasone; DNA-Binding Proteins; Electrophoresis; Gene Expression Regulation, Neoplastic; Humans; Interleukin-6; Mifepristone; Mutagenesis, Site-Directed; Nuclear Proteins; Promoter Regions, Genetic; Recombinant Proteins; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured | 1998 |
Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
Topics: Adenocarcinoma; Androgens; Animals; Binding Sites; Estradiol; Female; Flutamide; Glucocorticoids; Gonanes; Hormone Antagonists; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mifepristone; Neoplasms, Hormone-Dependent; Oligonucleotides, Antisense; Ovariectomy; Receptors, Estrogen; Receptors, Progesterone; Thymidine; Tumor Cells, Cultured | 1999 |
Glucocorticoid blockade does not abrogate tumor-induced cachexia.
Topics: Adenocarcinoma; Animals; Body Composition; Body Weight; Cachexia; Colonic Neoplasms; Female; Glucocorticoids; Hormone Antagonists; Interleukin-6; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mifepristone; Neoplasm Transplantation; Regression Analysis; Tumor Cells, Cultured | 1999 |
High-dose progesterone inhibition of urokinase secretion and invasive activity by SKOV-3 ovarian carcinoma cells: evidence for a receptor-independent nongenomic effect on the plasma membrane.
Topics: Adenocarcinoma; Cell Membrane; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Mifepristone; Neoplasm Invasiveness; Ovarian Neoplasms; Progesterone; Receptors, Progesterone; Testosterone; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2001 |
Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Basement Membrane; Cell Communication; Cell Differentiation; Cell Division; Coculture Techniques; Collagen; Culture Media; Drug Combinations; Endometrial Neoplasms; Endometrium; Estrogens; Female; Glycodelin; Glycoproteins; Humans; Laminin; Mifepristone; Pregnancy Proteins; Progesterone; Proteoglycans; Stromal Cells; Tissue Extracts | 2002 |
Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line.
Topics: Adenocarcinoma; Aldosterone; Annexins; Antibodies, Monoclonal; Calcium-Binding Proteins; Cell Division; Cell Membrane; Dexamethasone; Dinoprostone; Dose-Response Relationship, Drug; Humans; Hydrocortisone; Indomethacin; Kinetics; Lung Neoplasms; Mifepristone; Naproxen; Phospholipases; Progesterone; Recombinant Proteins | 1992 |
The biological effects of macrophage-colony-stimulating factor induced by progestin on growth and differentiation of endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Cell Differentiation; Female; Genes, fms; Humans; Macrophage Colony-Stimulating Factor; Mifepristone; Progestins; Receptor, Macrophage Colony-Stimulating Factor; RNA, Messenger; Tumor Cells, Cultured; Uterine Neoplasms | 1991 |
Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line.
Topics: Adenocarcinoma; Animals; Cat Diseases; Cats; Cell Division; DNA Replication; Drug Synergism; Epidermal Growth Factor; ErbB Receptors; Female; Mammary Neoplasms, Animal; Mifepristone; Neoplasms, Hormone-Dependent; Phosphorylation; Progesterone; Progestins; Promegestone; Receptors, Progesterone; Tumor Cells, Cultured | 1991 |
Comparison of the actions of RU 38486 and megestrol acetate in the model of a transplantable adrenocorticotropin- and prolactin-secreting rat pituitary tumor.
Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Animals; Body Weight; Cells, Cultured; Estrenes; Female; Megestrol; Megestrol Acetate; Mifepristone; Neoplasm Transplantation; Organ Size; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid | 1985 |